RECEPTOR TYROSINE KINASES AND CHEMOKINE RECEPTORS COOPERATE IN STIMULATING TUMORS METASTATIC BEHAVIO - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

RECEPTOR TYROSINE KINASES AND CHEMOKINE RECEPTORS COOPERATE IN STIMULATING TUMORS METASTATIC BEHAVIO

Description:

Krakow, Poland. Normal and pathological cell behavior (e.g. growth, faith, motility) is govern ... Several families of surface receptors has been discovered. ... – PowerPoint PPT presentation

Number of Views:42
Avg rating:3.0/5.0
Slides: 31
Provided by: plastm
Category:

less

Transcript and Presenter's Notes

Title: RECEPTOR TYROSINE KINASES AND CHEMOKINE RECEPTORS COOPERATE IN STIMULATING TUMORS METASTATIC BEHAVIO


1
RECEPTOR TYROSINE KINASES AND CHEMOKINE RECEPTORS
COOPERATE IN STIMULATING TUMORS METASTATIC
BEHAVIOR
  • Marcin Majka and Katarzyna Miekus
  • Department of Transplantation
  • Jagiellonian University Medical College
  • Krakow, Poland

2
Introduction
  • Normal and pathological cell behavior (e.g.
    growth, faith, motility) is govern by various
    extracellular signals transmitted by cell surface
    receptors.
  • Several families of surface receptors has been
    discovered. They transmit signals stimulating or
    inhibiting proliferation, apoptosis,
    differentiation.
  • In physiological and pathological settings each
    cell constantly receives signals from several
    different receptors and these signals
    interconnect with each other.

3
MET and CXCR4 receptors in tumor biology
4
MET receptor tyrosine kinase
  • MET receptor, encoded by MET proto-oncogene, has
    been shown to play a very important role in
    development and progression of various tumors.
  • MET activity is a key event during tumor
    metastasis and MET overexpression and
    hyperactivation have been reported to correlate
    with metastatic ability of the tumor cells.

5
Role of HGF-MET axis in tumor growth and
metastasis
  • proliferation
  • survival
  • motility

6
CXCR4 a G-protein coupled chemokine receptor
  • CXCR4
  • a receptor for stromal derived factor -1
    (SDF-1) expressed on e.g. HSC, lymphoid cells,
    endothelium and tumor cells (e.g. neuroblastoma,
    breast cancer, rhabdomyosarcoma, cervical
    carcinoma)
  • SDF-1
  • a chemokine, constitutively expressed in several
    tissues (e.g. lung, bone marrow) directs
    migration of normal and tumor cells

7
Role of SDF-1-CXCR4 axis in tumor growth and
metastasis
  • growth
  • vascularization
  • local spread
  • metastasis

Burger JA and Kipps TJ Blood 2006
8
Rhabdomyosarcoma
  • Rhabdomyosarcoma (RMS) is the most common soft
    tissue sarcoma developing in children and
    adolescent
  • For newly diagnosed RMS patients the long term
    prognosis is good. However, the survival rate of
    patients with metastasic disease is only 20

9
The migratory ability of MET negative cells
10
Reduction of CXCR4 expression and activation in
MET negative cells
11
Inhibition of intracellular pathways
activation in MET negative cell lines
Rhabdomyosarcoma
12
Downregulation of MET receptor blocks
angiogenesis in RMS cells
13
RMS tumor growth is inhibited by MET receptor
downregulation

14
MET negative cells undergo differentiation in
vivo
15
Metastatic ability of RMS cell is reduced by MET
inhibition
ERMS
ARMS
16
Cervical carcinoma
  • Cervical carcinoma is a leading cause of deaths
    among women suffering from cancer
  • Early-stage cervical cancer is curable in most
    patients
  • In Poland about 4000 women are diagnosed with
    cervical cancer every year and the 5-year
    survival rate is one of the lowest in Europe

17
Morphology of MET negative cervical carcinoma
cell line
WT
shLacZ
shMET
18
(No Transcript)
19
Reduced tumor growth of MET negative cervical
carcinoma cell line
weight of tumor g
20
Histopathology study of tumors formed by control
and MET negative tumor cells
Hematoxylin/eosin-stained paraffin sections of
the tumors lesions
21
Decreased expression of CXCR4 and migration
toward SDF-1 gradient by MET negative cervical
carcinoma cells
22
Inhibition of intracellular pathways
activation in MET negative cervical cell lines
23
Bone marrow appearance after HTB-35 cell line
injection
shLacZ
shMET
WT
24
  • Expression of MET and CXCR4 in
  • differentiated RMS cells

25
Pharmacological differentiation of RMS cells
26
MET and CXCR4 expression and activation in
differentiated RMS cells
27
Conclusions
  • Inhibition of MET signaling decreases ability of
    rhabdomyosarcoma and cervical carcinoma to
    migrate and metastasise
  • Expression and function of CXCR4 receptor in
    rhabdomyosarcoma and cervical carcinoma is
    closely related to the presence and activation of
    HGF-MET axis

28
Conclusions
  • Presence of MET receptor is responsible for
    keeping ARMS in less differentiated state
  • Induction of rhabdomyosarcoma differentiation
    couses downregulation of MET and CXCR4 expression
    and reduced metastatic ability of rabdomyosarcoma
    cells in vitro and in vivo

29
Conclusions
  • Presence of one type of the receptor could be
    crucial to induce full activation of another type
    of the receptor

30
Acknowledgments
  • Department of Transplantation
  • Ewa Lukasiewicz
  • Jacek Kijowski
  • Department of Clinical Immunology
  • Grazyna Drabik
  • Robert Miezynski
  • Department of Cell Biology
  • Zbigniew Madeja
  • Ewa Wybieralska
Write a Comment
User Comments (0)
About PowerShow.com